1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPATA13 CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA CITED1 CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA SOHLH1 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA GKAP1 CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA ENTPD6 CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA C19orf71 CTRPv2 pan-cancer AAC 0.17 5e-05
mRNA TMTC2 CTRPv2 pan-cancer AAC 0.17 5e-05
mRNA SERPINB5 CTRPv2 pan-cancer AAC 0.17 5e-05
mRNA FCER1G CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA BIN3 CTRPv2 pan-cancer AAC 0.2 5e-05
Download CSV